Curtiss-Wright (NYSE: CW) CFO reports performance grant and tax-related sale

Rhea-AI Filing Summary

Curtiss-Wright Corporation’s Executive VP and CFO K. Christopher Farkas reported a performance-based stock grant and a related share sale. On February 3, 2026, he acquired 5,770 shares of common stock through a performance share grant under the company’s 2014 Long Term Incentive Plan, valued using the $674.32 NYSE closing price on the vesting date.

On February 4, 2026, he sold 2,665 shares at an average price of $626.33, with prices ranging from $609.29 to $660.49, to cover individual income tax obligations tied to vesting. After these transactions, he directly owned 7,358 shares of Curtiss-Wright common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farkas K Christopher

(Last) (First) (Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/03/2026		A(1)		5,770	A	$674.32(2)	10,023	D
Common Stock	02/04/2026		S(3)		2,665	D	$626.33(4)	7,358	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were acquired through a performance share grant under the Company's 2014 Long Term Incentive Plan, whereby the executive received a predetermined number of shares of Curtiss-Wright Common Stock based on the Company's three-year total shareholder return against the performance of its peer group.

2. Based on February 3, 2026 closing price on the New York Stock Exchange for Curtiss-Wright Common Stock, the date on which the shares vested.

3. Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell a portion of the vested shares to cover individual income tax obligations associated with the vesting of the award.

4. The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $609.29 to $660.49, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Remarks:

	George P. McDonald by Power of Attorney from K. Christopher Farkas	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Curtiss-Wright (CW) CFO K. Christopher Farkas report?

Curtiss-Wright’s CFO reported a performance share grant and a follow-on sale. He acquired 5,770 shares on February 3, 2026, then sold 2,665 shares on February 4, 2026, primarily to cover income tax obligations from the vesting event.

How many Curtiss-Wright (CW) shares does the CFO own after these Form 4 transactions?

After the reported transactions, Curtiss-Wright’s CFO directly owns 7,358 shares of common stock. This figure reflects the 5,770-share grant received on February 3, 2026, and the 2,665 shares sold on February 4, 2026, to address tax obligations.

What price was used to value the Curtiss-Wright (CW) performance share grant?

The performance share grant was valued using the February 3, 2026 NYSE closing price of $674.32 per Curtiss-Wright common share. That date corresponds to when the 5,770 granted shares vested under the company’s 2014 Long Term Incentive Plan.

Why did the Curtiss-Wright (CW) CFO sell 2,665 shares after the grant vested?

The CFO sold 2,665 shares to comply with Curtiss-Wright’s share ownership guidelines, which allow executives to sell vested shares to cover personal income tax obligations arising from the award’s vesting. The sale helped address those tax liabilities.

At what prices were the Curtiss-Wright (CW) CFO’s shares sold according to the Form 4?

The reported average sale price was $626.33 per share. The Form 4 notes the shares were sold in multiple transactions, with individual prices ranging from $609.29 to $660.49, and offers full breakdowns upon request to regulators, the issuer, or shareholders.

How was the Curtiss-Wright (CW) CFO’s performance share grant determined?

The grant was made under Curtiss-Wright’s 2014 Long Term Incentive Plan. The number of shares, 5,770, was based on the company’s three-year total shareholder return compared with a designated peer group, linking executive compensation to long-term relative performance.